Dar Zavain (CIK 1852075) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy RXRX (5,109 shares), Buy RXRX (88,424 shares), Buy RXRX (4,902 shares), Buy RXRX (3,571 shares), Buy RXRX (2,941 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Buy | 5,109 | $0 |
| 2026-06-22 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Buy | 88,424 | $0 |
| 2026-04-02 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Buy | 4,902 | $0 |
| 2026-01-06 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Buy | 3,571 | $0 |
| 2025-10-03 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Buy | 2,941 | $0 |
| 2025-07-03 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Buy | 2,924 | $0 |
| 2025-06-23 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Buy | 22,016 | $0 |
| 2025-04-03 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Buy | 2,745 | $0 |
Source: SEC Form 4 filings · as of 2026-07-02